John Shea of the San Francisco Chronicle asks whether Jeff Kent gets extra credit, if you will, when he’s up for the Hall of Fame next year due to the fact that he was an outspoken critic of baseball’s lack of drug testing:
Perhaps more than any other ballplayer, Kent lobbied for testing when it wasn’t trendy, when the union and much of its membership fought against it. In a clubhouse in which Greg Anderson once had free rein as a drug runner for Bonds and other Giants, Kent often stood at his locker and called for Major League Baseball and the union to iron out a legitimate steroids policy.
Shea details more of the ways in which Kent demonstrated his disapproval of PEDs in baseball.
Which is well and good, but I also wonder why, given the lessons of recent history, any athlete is to be take at his word with respect to PEDs, either positively or negatively.
Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.
It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.
Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.
A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.